Page last updated: 2024-10-30

metformin and Teratogenesis

metformin has been researched along with Teratogenesis in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Teratogenesis: The formation of CONGENITAL ABNORMALITIES.

Research Excerpts

ExcerptRelevanceReference
"Metformin has been prescribed in pregnancy for over 40 years; for much of this time, use has been limited both in numbers and geographically, and the evidence base has been confined to observational studies."8.95Metformin use in pregnancy: promises and uncertainties. ( Lindsay, RS; Loeken, MR, 2017)
"Metformin has been prescribed in pregnancy for over 40 years; for much of this time, use has been limited both in numbers and geographically, and the evidence base has been confined to observational studies."4.95Metformin use in pregnancy: promises and uncertainties. ( Lindsay, RS; Loeken, MR, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindsay, RS1
Loeken, MR1

Reviews

1 review available for metformin and Teratogenesis

ArticleYear
Metformin use in pregnancy: promises and uncertainties.
    Diabetologia, 2017, Volume: 60, Issue:9

    Topics: Female; Humans; Hypoglycemic Agents; Metformin; Pregnancy; Teratogenesis

2017